Breast Lobular Carcinoma — Trials

Breast Lobular Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

81 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 26
Recruiting: 15
Ph III recruiting: 0
Growth YoY: —
Industry share: 8%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (10)

clinicaltrialsPublishedShowing 1–8 of 8 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06033092	Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion(TOLERANT)	completed	Phase 2	110	European Institute of OncologyOTHER	1	Sep 11, 2026	clinicaltrials
NCT02928978	Ruxolitinib for Premalignant Breast Disease(TBCRC042)	completed	Phase 2	84	Julie NangiaOTHER	1	Apr 13, 2026	clinicaltrials